As costs for cancer care continue to rise, Pontchartrain Cancer Center does benefit and cost analyses for all patients before they start therapy and also takes into account any social needs they might have, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center.
As costs for cancer care continue to rise, Pontchartrain Cancer Center does benefit and cost analyses for all patients before they start therapy and also takes into account any social needs they might have, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center.
Transcript
How are you providing financial counseling assistance to the patients at Pontchartrain Cancer Center?
So, every patient that we see prior to the initiation of therapy, we do a benefit analysis as well as a cost analysis for them of their co-pays, their deductible, and everything. And anything that is $50 or more triggers our financial assistance people to then go in a look for assistance for those people to be able to afford their therapy.
But going back to my more rural market, we’ve now changed that to look for financial assistance for everyone. Because $50 for 1 person might look very different an $50 for another person.
So, in addition to financial help, we’ve really started addressing the patient as a whole in addressing all of their social needs as well. So, we look for transportation, help with their electricity, rent—so, our program that was once just financial offerings we’ve increased it 10-fold over the last 18 months as costs continue to rise and rise for our patients.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen